CLOV: Bathi resik saben saham (EPS TTM) Clover Health Corp

Clover Health Investments (CLOV) is expanding Medicare Advantage through IT solutions, aiming for software licensing. Net income per share over the last 12 months confirms the trend, where the value of 0.02 serves as the current metric. Efficiency relies on risk management precision and government payments. The strategy excludes mergers, focusing instead on onboarding physicians into the digital environment to achieve break-even.

This metric measures the actual return per share, excluding the impact of issuance and reflecting the net financial result for the year. For Clover Health Investments (CLOV), this indicator demonstrates the efficiency of integrating the AI platform into Medicare Advantage insurance plans, which is clearly evidenced by the 12-month net income per share chart through the lens of the Insurtech business's ability to generate profit.